Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease

Behavioural Neurology

Volumn 2015, Issue , 2015, Pages

  Casaca Carreira, João ^a,b   Temel, Yasin ^a,b   Van Zelst, Marloes ^a   Jahanshahi, Ali ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b European Graduate School of Neuroscience   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERAGE SPEED; BASAL GANGLION; BASE OF SUPPORT; BEHAVIOR; BODY MOVEMENT; CADENCE; CATWALK GAIT ANALYSIS TEST; CHOREA; CONTROLLED STUDY; EXPERIMENTAL DISEASE; GAIT DISORDER; HUNTINGTON CHOREA; MALE; MOTOR PERFORMANCE; MUSCULOSKELETAL SYSTEM PARAMETERS; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; NUMBER OF STEP; PAW; PRIORITY JOURNAL; RAT; RAT MODEL; STEP CYCLE; STRIDE LENGTH; SWING SPEED; TRANSGENIC RAT; WILD TYPE; ANIMAL; BRAIN; COGNITIVE DEFECT; COMPLICATION; DISEASE MODEL; GAIT; MOTOR DYSFUNCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; GAIT; HUNTINGTON DISEASE; MALE; MOVEMENT DISORDERS; RATS, TRANSGENIC;

EID: 84929650469     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.1155/2015/970204     Document Type: Article

References (30)

1. M. Macdonald, "A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes," Cell, vol. 72, no. 6, pp. 971-983, 1993.
2. R. I. Scahill, N. Z. Hobbs, M. J. Say et al., "Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy," Human Brain Mapping, vol. 34, no. 3, pp. 519-529, 2013.
3. Y. M. A. Grimbergen, M. J. Knol, B. R. Bloem, B. P. H. Kremer, R. A. C. Roos, and M. Munneke, "Falls and gait disturbances in Huntington's disease," Movement Disorders, vol. 23, no. 7, pp. 970-976, 2008.
4. K. M. Biglan, C. A. Ross, D. R. Langbehn et al., "Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study," Movement Disorders, vol. 24, no. 12, pp. 1763-1772, 2009.
5. F. O. Walker, "Huntington's disease," The Lancet, vol. 369, no. 9557, pp. 218-228, 2007.
6. W. C. Koller and J. Trimble, "The gait abnormality of Huntington's disease," Neurology, vol. 35, no. 10, pp. 1450-1454, 1985.
7. A. Delval, P. Krystkowiak, J.-L. Blatt et al., "Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study," Journal of Neurology, vol. 253, no. 1, pp. 73-80, 2006.
8. B. Bilney, M. E. Morris, A. Churchyard, E. Chiu, and N. Georgiou-Karistianis, "Evidence for a disorder of locomotor timing in Huntington's disease," Movement Disorders, vol. 20, no. 1, pp. 51-57, 2005.
9. D. H. Zeef, A. Jahanshahi, R. Vlamings et al., "An experimental model for Huntington's chorea?" Behavioural Brain Research, vol. 262, pp. 31-34, 2014.
10. N. C. Reynolds Jr., J. B. Myklebust, T. E. Prieto, and B. M. Myklebust, "Analysis of gait abnormalities in Huntington disease," Archives of Physical Medicine and Rehabilitation, vol. 80, no. 1, pp. 59-65, 1999.
11. S. J. Augood, R. L. M. Faull, and P. C. Emson, "Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease," Annals of Neurology, vol. 42, no. 2, pp. 215-221, 1997.
12. M. Glass, M. Dragunow, and R. L. M. Faull, "The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease," Neuroscience, vol. 97, no. 3, pp. 505-519, 2000.
13. S. Goto, A. Hirano, and R. R. Rojas-Corona, "Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders," Acta Neuropathologica, vol. 78, no. 5, pp. 543-550, 1989.
14. E. K. Richfield, K. A. Maguire-Zeiss, C. Cox, J. Gilmore, and P. Voorn, "Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients," Annals of Neurology, vol. 37, no. 3, pp. 335-343, 1995.
15. E. K. Richfield, K. A. Maguire-Zeiss, H. E. Vonkeman, and P. Voorn, "Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients," Annals of Neurology, vol. 38, no. 6, pp. 852-861, 1995.
16. E. K. Richfield, C. F. O'Brien, T. Eskin, and I. Shoulson, "Heterogeneous dopamine receptor changes in early and late Huntington's disease," Neuroscience Letters, vol. 132, no. 1, pp. 121-126, 1991.
17. S. von Horsten, I. Schmitt, H. P. Nguyen et al., "Transgenic rat model of Huntington's disease," Human Molecular Genetics, vol. 12, no. 6, pp. 617-624, 2003.
18. J. C. Carreira, A. Jahanshahi, D. Zeef et al., "Transgenic rat models of Huntington's disease," in Current Topics in Behavioral Neurosciences, Springer, Berlin, Germany, 2013.
19. R. Vlamings, D. H. Zeef, M. L. F. Janssen et al., "Lessons learned from the transgenic Huntington's disease rats," Neural Plasticity, vol. 2012, Article ID 682712, 8 pages, 2012.
20. C. Cao, Y. Temel, A. Blokland et al., "Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel," Behavioural Brain Research, vol. 170, no. 2, pp. 257-261, 2006.
21. C. Vandeputte, J.-M. Taymans, C. Casteels et al., "Automated quantitative gait analysis in animal models of movement disorders," BMC Neuroscience, vol. 11, article 92, 2010.
22. F. P. T. Hamers, A. J. Lankhorst, T. J. Van Laar, W. B. Veldhuis, and W. H. Gispen, "Automated quantitative gait analysis during overground locomotion in the rat: Its application to spinal cord contusion and transection injuries," Journal of Neurotrauma, vol. 18, no. 2, pp. 187-201, 2001.
23. L. Yu-Taeger, E. Petrasch-Parwez, A. P. Osmand et al., "A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease," Journal of Neuroscience, vol. 32, no. 44, pp. 15426-15438, 2012.
24. J. E. Westin, M. L. F. Janssen, T. N. Sager, and Y. Temel, "Automated gait analysis in bilateral Parkinsonian rats and the role of L-DOPA therapy," Behavioural Brain Research, vol. 226, no. 2, pp. 519-528, 2012.
25. D. H. Zeef, R. Vlamings, L. W. Lim et al., "Motor and non-motor behaviour in experimental Huntington's disease," Behavioural Brain Research, vol. 226, no. 2, pp. 435-439, 2012.
26. F. P. T. Hamers, G. C. Koopmans, and E. A. J. Joosten, "CatWalk-assisted gait analysis in the assessment of spinal cord injury," Journal of Neurotrauma, vol. 23, no. 3-4, pp. 537-548, 2006.
27. R. Vlamings, V. Visser-Vandewalle, G. Koopmans et al., "High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats," Neuroscience, vol. 148, no. 3, pp. 815-823, 2007.
28. A. Jahanshahi, R. Vlamings, W. M. C. van Roon-Mom et al., "Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington's disease," Neuroscience, vol. 238, pp. 71-81, 2013.
29. A. Jahanshahi, R. Vlamings, A. H. Kaya et al., "Hyperdopaminergic status in experimental Huntington disease," Journal of Neuropathology & Experimental Neurology, vol. 69, no. 9, pp. 910-917, 2010.
30. J. Collett, P. Esser, H. Khalil et al., "Insights into gait disorders: walking variability using phase plot analysis, Huntington's disease," Gait & Posture, vol. 40, no. 4, pp. 694-700, 2014.